Science
Lyell Immunopharma Inc (NASDAQ:LYEL) Has Recovered -4.43 Percent This Year, But Further Gains Of -115.89% Are Not Out Of The Question.
In last trading session, Lyell Immunopharma Inc (NASDAQ:LYEL) saw 0.6 million shares changing hands with its beta currently measuring -0.53. Company’s recent per share price
